CLT-008 (Human Myeloid Progenitor Cells)

· Cellerant Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLT-008 (Human Myeloid Progenitor Cells), covering 2016-07-01 to 2016-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia [Phase 1, Phase 2]